- Bachelor's or higher degree in Engineering, Computer Science, Biotechnology, or a related field
- 2+ years of experience developing and programming liquid handling automation methods. Experience on Tecan Fluent preferred.
- Hands-on experience coding in Biosero's Green Button Go (GBG) software, or equivalent scheduling software experience
- Proficiency in programming languages such as Python or C#
- Experience working cross-functionally to platform manual assays onto automated systems
- Familiarity with flow cytometry, genomic, and cell-based assays
- Experience with laboratory analytical instruments and automated systems
- Familiarity with GMP documentation and change control practices, or ability to quickly learn regulated documentation requirements
- Strong technical writing skills and experience authoring SOPs, documentation, and training materials
- Excellent problem-solving skills and ability to troubleshoot technical issues during method development
- Strong communication skills to collaborate effectively with cross-functional teams
- Attention to detail and ability to manage multiple development efforts simultaneously
- Creative, self-motivated, eager to take on a wide variety of tasks and grow with the evolving technology
- Self-awareness, integrity, authenticity, and a growth mindset
This is Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation.
Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.